NASDAQ$ADUS

Addus HomeCare Corporation · Q1 2022 earnings

Q1 2022 earnings · · Investor relations

Briefing

Addus reported strong financial results for Q1 2022, with revenue growth driven by hospice and home health segments, despite challenges from the Omicron variant.

Addus HomeCare Corporation announced its financial results for the first quarter ended March 31, 2022, with revenues growing 10.4% to $226.6 million. Net income was $8.5 million, or $0.53 per diluted share, while adjusted earnings per diluted share increased to $0.77. The company experienced positive trends across all operating segments, reflecting favorable demand for home-based care.

  • Revenues grew by 10.4% to $226.6 million compared to Q1 2021.
  • Net income reached $8.5 million, with earnings per diluted share at $0.53.
  • Adjusted earnings per diluted share increased to $0.77.
  • Hospice same store revenue increased by 4.4%.

Headline financials

Total Revenue

$227M

Previous: $205M+10.4%
EPS (adj)

$0.77

Previous: $0.74+4.1%
Capital Expenditures

-$1.1M

Previous: -$1.02M-8.1%
Free Cash Flow

$7.37M

Previous: $7.87M-6.4%
Net Income

$8.47M

Previous: $8.89M-4.8%
Operating Income

$13.5M

Previous: $12.2M+11.0%
Gross Profit

$70.2M

Previous: $61.2M+14.7%
Cash & Equivalents

$125M

Previous: $126M-0.6%
Total Assets

$987M

Previous: $878M+12.5%
Stock-Based Comp

$2.49M

Previous: $2.24M+11.0%

Revenue & EPS history

Addus · Revenue · Quarterly

$227M

Q1 2022+10.4%vs Q1 2021
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

Addus · $227M total across 3 segments · Q1 2022

  • Personal Care
    $170M+2.9%
  • Hospice
    $47.7M+32.2%
  • Home Health
    $9.28M+113.7%

Forward guidance

Addus is optimistic about its prospects for continued organic growth and strategic acquisitions in 2022, driven by the increasing demand for home-based care and the company's established operating model.

Tailwinds

  • Favorable demand trends for home-based care.
  • Significant prospects for continued organic growth in current markets.
  • Opportunities to enter new markets through selective acquisitions.
  • Focus on acquiring clinical services capabilities in existing markets.
  • Advancing strategy to expand to more states with full home care coverage.

Headwinds

  • Potential risks associated with discretionary determinations by government officials.
  • Challenges in consummating and integrating acquisitions.
  • Unexpected increases in SG&A and other expenses.
  • Changes in reimbursement and government regulations.
  • Uncertainty regarding the outcome of discussions with managed care organizations.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2022

Historical avgQ1 2022

+1.2%

Avg return

Earnings day

+2.3%

Avg return

5 days after

+5.0%

Avg return

30 days after

58%

37 / 64 earnings

Positive

+23.7%

Q4 2019

Best reaction

-19.6%

Q4 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.7%-0.6%-10.6%
Q4 2025-9.1%-12.0%-17.0%
Q3 2025-5.9%-5.0%-4.1%
Q1 2025+4.1%+6.3%+7.5%
Q4 2024-10.4%-12.0%-10.1%
Q3 2024-1.7%+1.0%-2.1%
Q2 2024+3.5%+3.6%+8.5%
Q1 2024+6.5%+11.3%+16.8%
Q4 2023+3.4%+5.3%+16.4%
Q3 2023-3.7%+3.3%+7.0%
Q2 2023+1.2%+3.9%-0.1%
Q1 2023+5.8%+0.3%+10.3%
Q4 2022+3.9%+2.5%-0.4%
Q3 2022+3.1%+3.8%+4.8%
Q2 2022+3.1%+0.6%-3.9%
Q1 2022-2.3%-4.7%-4.2%
Q4 2021+20.5%+20.4%+15.8%
Q3 2021-0.5%+9.1%-8.9%
Q2 2021+9.1%+5.3%+4.0%
Q1 2021-6.6%-8.1%-10.0%
Q4 2020-11.3%-14.2%-11.3%
Q3 2020+11.9%+10.3%+4.6%
Q2 2020+2.7%-4.6%-7.1%
Q1 2020+10.2%+2.7%+22.5%
Q4 2019+23.7%+8.5%+42.1%
Q3 2019-0.9%-0.1%+8.6%
Q2 2019+1.4%+4.4%-0.2%
Q1 2019+3.6%+3.0%+8.8%
Q4 2018-2.8%-7.8%-3.8%
Q3 2018+6.5%+10.8%+16.7%
Q2 2018-4.4%-7.1%-3.4%
Q1 2018+3.1%+1.8%+11.9%
Q4 2017-0.3%+8.6%+38.5%
Q3 2017-1.4%-5.8%-7.8%
Q2 2017-0.3%-1.4%-1.3%
Q1 2017+11.3%+9.4%+2.6%
Q4 2016+1.2%+0.1%-7.5%
Q3 2016+17.4%+28.7%+32.7%
Q2 2016+13.8%+8.6%+27.1%
Q1 2016-1.1%
Q4 2015-16.6%
Q3 2015-12.7%
Q2 2015+4.4%
Q1 2015-3.4%
Q4 2014+3.7%
Q3 2014+7.1%
Q2 2014+1.3%
Q1 2014+1.8%
Q4 2013-19.6%
Q3 2013+4.3%
Q2 2013+9.3%
Q1 2013+0.9%
Q4 2012+13.2%
Q3 2012+10.5%
Q2 2012+1.1%
Q1 2011-0.0%
Q1 2012-7.8%
Q4 2011+6.6%
Q3 2010-1.3%
Q3 2011-1.3%
Q2 2011-17.3%
Q2 2010-17.3%
Q4 2010+0.2%
Q1 2010+2.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro